The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
RNAi Technologies-Global Market Insights and Sales Trends 2024
Synopsis
RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and therapeutics.
The global RNAi Technologies market size is expected to reach US$ 430.3 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of RNAi Technologies in various end use industries. The expanding demands from the Research and Therapeutics, are propelling RNAi Technologies market. Oncology, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ocular Disorders segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for RNAi Technologies market, driven by demand from China, the second largest economy with some signs of stabilising, the RNAi Technologies market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for RNAi Technologies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global RNAi Technologies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global RNAi Technologies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, RNAi Technologies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of RNAi Technologies covered in this report include Alnylam Pharmaceuticals, Benitec Biopharma Ltd, Filmtec Corporation, Ionis Pharmaceuticals, Quark Pharmaceuticals Inc., RXI Pharmaceuticals, Qiagen, Invitrogen and Ambion, etc.
The global RNAi Technologies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alnylam Pharmaceuticals
Benitec Biopharma Ltd
Filmtec Corporation
Ionis Pharmaceuticals
Quark Pharmaceuticals Inc.
RXI Pharmaceuticals
Qiagen
Invitrogen
Ambion
Global RNAi Technologies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global RNAi Technologies market, Segment by Type:
Oncology
Ocular Disorders
Respiratory Disorders
Liver Diseases
Other
Global RNAi Technologies market, by Application
Research
Therapeutics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of RNAi Technologies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and therapeutics.
The global RNAi Technologies market size is expected to reach US$ 430.3 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of RNAi Technologies in various end use industries. The expanding demands from the Research and Therapeutics, are propelling RNAi Technologies market. Oncology, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ocular Disorders segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for RNAi Technologies market, driven by demand from China, the second largest economy with some signs of stabilising, the RNAi Technologies market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for RNAi Technologies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global RNAi Technologies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global RNAi Technologies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, RNAi Technologies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of RNAi Technologies covered in this report include Alnylam Pharmaceuticals, Benitec Biopharma Ltd, Filmtec Corporation, Ionis Pharmaceuticals, Quark Pharmaceuticals Inc., RXI Pharmaceuticals, Qiagen, Invitrogen and Ambion, etc.
The global RNAi Technologies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alnylam Pharmaceuticals
Benitec Biopharma Ltd
Filmtec Corporation
Ionis Pharmaceuticals
Quark Pharmaceuticals Inc.
RXI Pharmaceuticals
Qiagen
Invitrogen
Ambion
Global RNAi Technologies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global RNAi Technologies market, Segment by Type:
Oncology
Ocular Disorders
Respiratory Disorders
Liver Diseases
Other
Global RNAi Technologies market, by Application
Research
Therapeutics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of RNAi Technologies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of RNAi Technologies
1.1 RNAi Technologies Market Overview
1.1.1 RNAi Technologies Product Scope
1.1.2 RNAi Technologies Market Status and Outlook
1.2 Global RNAi Technologies Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global RNAi Technologies Market Size by Region (2018-2029)
1.4 Global RNAi Technologies Historic Market Size by Region (2018-2023)
1.5 Global RNAi Technologies Market Size Forecast by Region (2024-2029)
1.6 Key Regions, RNAi Technologies Market Size (2018-2029)
1.6.1 North America RNAi Technologies Market Size (2018-2029)
1.6.2 Europe RNAi Technologies Market Size (2018-2029)
1.6.3 Asia-Pacific RNAi Technologies Market Size (2018-2029)
1.6.4 Latin America RNAi Technologies Market Size (2018-2029)
1.6.5 Middle East & Africa RNAi Technologies Market Size (2018-2029)
2 RNAi Technologies Market by Type
2.1 Introduction
2.1.1 Oncology
2.1.2 Ocular Disorders
2.1.3 Respiratory Disorders
2.1.4 Liver Diseases
2.1.5 Other
2.2 Global RNAi Technologies Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global RNAi Technologies Historic Market Size by Type (2018-2023)
2.2.2 Global RNAi Technologies Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America RNAi Technologies Revenue Breakdown by Type (2018-2029)
2.3.2 Europe RNAi Technologies Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific RNAi Technologies Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America RNAi Technologies Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa RNAi Technologies Revenue Breakdown by Type (2018-2029)
3 RNAi Technologies Market Overview by Application
3.1 Introduction
3.1.1 Research
3.1.2 Therapeutics
3.2 Global RNAi Technologies Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global RNAi Technologies Historic Market Size by Application (2018-2023)
3.2.2 Global RNAi Technologies Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America RNAi Technologies Revenue Breakdown by Application (2018-2029)
3.3.2 Europe RNAi Technologies Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific RNAi Technologies Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America RNAi Technologies Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa RNAi Technologies Revenue Breakdown by Application (2018-2029)
4 RNAi Technologies Competition Analysis by Players
4.1 Global RNAi Technologies Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in RNAi Technologies as of 2022)
4.3 Date of Key Players Enter into RNAi Technologies Market
4.4 Global Top Players RNAi Technologies Headquarters and Area Served
4.5 Key Players RNAi Technologies Product Solution and Service
4.6 Competitive Status
4.6.1 RNAi Technologies Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Alnylam Pharmaceuticals
5.1.1 Alnylam Pharmaceuticals Profile
5.1.2 Alnylam Pharmaceuticals Main Business
5.1.3 Alnylam Pharmaceuticals RNAi Technologies Products, Services and Solutions
5.1.4 Alnylam Pharmaceuticals RNAi Technologies Revenue (US$ Million) & (2018-2023)
5.1.5 Alnylam Pharmaceuticals Recent Developments
5.2 Benitec Biopharma Ltd
5.2.1 Benitec Biopharma Ltd Profile
5.2.2 Benitec Biopharma Ltd Main Business
5.2.3 Benitec Biopharma Ltd RNAi Technologies Products, Services and Solutions
5.2.4 Benitec Biopharma Ltd RNAi Technologies Revenue (US$ Million) & (2018-2023)
5.2.5 Benitec Biopharma Ltd Recent Developments
5.3 Filmtec Corporation
5.3.1 Filmtec Corporation Profile
5.3.2 Filmtec Corporation Main Business
5.3.3 Filmtec Corporation RNAi Technologies Products, Services and Solutions
5.3.4 Filmtec Corporation RNAi Technologies Revenue (US$ Million) & (2018-2023)
5.3.5 Ionis Pharmaceuticals Recent Developments
5.4 Ionis Pharmaceuticals
5.4.1 Ionis Pharmaceuticals Profile
5.4.2 Ionis Pharmaceuticals Main Business
5.4.3 Ionis Pharmaceuticals RNAi Technologies Products, Services and Solutions
5.4.4 Ionis Pharmaceuticals RNAi Technologies Revenue (US$ Million) & (2018-2023)
5.4.5 Ionis Pharmaceuticals Recent Developments
5.5 Quark Pharmaceuticals Inc.
5.5.1 Quark Pharmaceuticals Inc. Profile
5.5.2 Quark Pharmaceuticals Inc. Main Business
5.5.3 Quark Pharmaceuticals Inc. RNAi Technologies Products, Services and Solutions
5.5.4 Quark Pharmaceuticals Inc. RNAi Technologies Revenue (US$ Million) & (2018-2023)
5.5.5 Quark Pharmaceuticals Inc. Recent Developments
5.6 RXI Pharmaceuticals
5.6.1 RXI Pharmaceuticals Profile
5.6.2 RXI Pharmaceuticals Main Business
5.6.3 RXI Pharmaceuticals RNAi Technologies Products, Services and Solutions
5.6.4 RXI Pharmaceuticals RNAi Technologies Revenue (US$ Million) & (2018-2023)
5.6.5 RXI Pharmaceuticals Recent Developments
5.7 Qiagen
5.7.1 Qiagen Profile
5.7.2 Qiagen Main Business
5.7.3 Qiagen RNAi Technologies Products, Services and Solutions
5.7.4 Qiagen RNAi Technologies Revenue (US$ Million) & (2018-2023)
5.7.5 Qiagen Recent Developments
5.8 Invitrogen
5.8.1 Invitrogen Profile
5.8.2 Invitrogen Main Business
5.8.3 Invitrogen RNAi Technologies Products, Services and Solutions
5.8.4 Invitrogen RNAi Technologies Revenue (US$ Million) & (2018-2023)
5.8.5 Invitrogen Recent Developments
5.9 Ambion
5.9.1 Ambion Profile
5.9.2 Ambion Main Business
5.9.3 Ambion RNAi Technologies Products, Services and Solutions
5.9.4 Ambion RNAi Technologies Revenue (US$ Million) & (2018-2023)
5.9.5 Ambion Recent Developments
6 North America
6.1 North America RNAi Technologies Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe RNAi Technologies Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific RNAi Technologies Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America RNAi Technologies Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa RNAi Technologies Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 RNAi Technologies Market Dynamics
11.1 RNAi Technologies Industry Trends
11.2 RNAi Technologies Market Drivers
11.3 RNAi Technologies Market Challenges
11.4 RNAi Technologies Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
